Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
Lamiae Grimaldi‐Bensouda(Conservatoire National des Arts et Métiers), Pierre Labauge(Centre Hospitalier Universitaire de Montpellier), Caroline Papeix(Sorbonne Université), Marie-France Courcoux(Sorbonne Université), Lucien Abenhaim(Serco (United Kingdom)), Pascal Hilliquin(Centre Hospitalier Sud Francilien), Violaine Foltz(Sorbonne Université), Jacques Bénichou(National Cancer Institute), Marc Nicolino(Hôpital Femme Mère Enfant), Jean‐François Viallard(Université de Bordeaux), N. Costedoat‐Chalumeau(Délégation Paris 5), Séverine Guillaume(Bicêtre Hospital), Patrick Berquin(Centre Hospitalier Universitaire Amiens-Picardie), Didier Guillemot(Inserm), Corinne Pondarré(Lyon 1 Université), Christine Lebrun‐Frénay(Université Côte d'Azur), Emmanuel Chatelus(Laboratoire National de Référence), Bertrand Godeau(Université Paris-Est Créteil), Albane Simon(École Nationale Supérieure d'Architecture de Versailles), M Rossignol(McGill University Health Centre), Alfred Penfornis(Enter (Switzerland)), P.‐Y. Benhamou(Centre Hospitalier Universitaire de Grenoble)
Cited by 135
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and Chondrocytes
|The American Journal of Human Genetics|2002|740
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432